<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-03T02:58:56Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/12173" metadataPrefix="ese">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/12173</identifier><datestamp>2026-09-30T00:05:29Z</datestamp><setSpec>com_10259_11209</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_11210</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington’s disease</dc:title>
<dc:creator>Saiz Rodríguez, Miriam</dc:creator>
<dc:creator>Gil Polo, Cecilia</dc:creator>
<dc:creator>Diez Fairen, Mónica</dc:creator>
<dc:creator>Martinez Horta, Saul Indra</dc:creator>
<dc:creator>Sampedro Santalo, Frederic</dc:creator>
<dc:creator>Calvo Simal, Sara</dc:creator>
<dc:creator>Alonso García, Esther</dc:creator>
<dc:creator>Riñones Mena, Esther</dc:creator>
<dc:creator>Aguado, Laura</dc:creator>
<dc:creator>Mariscal, Natividad</dc:creator>
<dc:creator>Muñoz Siscart, Ignacio</dc:creator>
<dc:creator>Piñeiro, Dolores</dc:creator>
<dc:creator>Rivadeneyra, Jessica</dc:creator>
<dc:creator>Cubo Delgado, Esther</dc:creator>
<dc:subject>Huntington’s disease</dc:subject>
<dc:subject>Oxytocin receptor</dc:subject>
<dc:subject>Polymorphisms</dc:subject>
<dc:subject>Enfermedad de Huntington</dc:subject>
<dc:subject>Huntington's disease</dc:subject>
<dc:description>Background Huntington’s disease (HD) is a neurodegenerative disorder characterized by cognitive, motor, and neuropsychiatric&#xd;
manifestations. Oxytocin is a neuropeptide studied for its role as a neuromodulator regulating multiple behaviors&#xd;
linked to social cognition. Genetic variation of oxytocin receptor (OXTR) might interact in the etiology and development&#xd;
of several impaired social behaviors. Our aim was to study OXTR polymorphisms and their relationship with apathy and&#xd;
social cognition in HD.&#xd;
Methods OXTR was sequenced in 21 cases and 22 controls. We assessed apathy, anxiety, depression, and irritability (Hospital&#xd;
Anxiety and Depression Scale-Snaith Irritability scale, HADS-SIS) and social cognition (Ekman 60 faces test), motor&#xd;
symptoms and functionality with the total functional capacity (TFC), and the Unified HD rating Scale (UHDRS).&#xd;
Results We identified ten variants in OXTR. Three variants were classified as possibly damaging (p.Arg40Gly) or probably&#xd;
damaging (p.Leu46Pro, p.Thr102Asn). Subjects carrying the wild-type genotype of the synonymous variant p.Val45 showed&#xd;
a significantly lower score in the HADS-SIS scale, related to lower irritability (p = 0.013). The only subject carrying the&#xd;
heterozygous genotype of the synonymous variant p.Leu62 showed a significantly higher score on Ekman scale, compared&#xd;
to wild-type (p = 0.049); however, this finding was not confirmed after bootstrapping.&#xd;
Conclusion Variations in OXTR could have a relevant role in the correct development of social and cognitive functions.&#xd;
Future approaches will include the molecular study of p.Arg40Gly, p.Leu46Pro, and p.Thr102Asn to confirm their pathogenicity,&#xd;
as well as the validation of the influence of p.Val45 and p.Leu62 variants for their involvement in irritability and&#xd;
social cognition in HD.</dc:description>
<dc:description>This project was partially funded by Gerencia Regional&#xd;
de Salud de Castilla y León (GRS 1768/A/18). M.S.R. contract was&#xd;
supported by Instituto de Salud Carlos III (ISCIII), Spanish Ministry&#xd;
of Science and Innovation, through the Sara Borrell Program&#xd;
(CD21/00022).</dc:description>
<dc:description>This project was partially funded by Gerencia Regional&#xd;
de Salud de Castilla y León (GRS 1768/A/18). M.S.R. contract was&#xd;
supported by Instituto de Salud Carlos III (ISCIII), Spanish Ministry&#xd;
of Science and Innovation, through the Sara Borrell Program&#xd;
(CD21/00022).</dc:description>
<dc:date>2026-09-29T08:09:30Z</dc:date>
<dc:date>2026-09-29T08:09:30Z</dc:date>
<dc:date>2022-06</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>1590-1874</dc:identifier>
<dc:identifier>https://hdl.handle.net/10259/12173</dc:identifier>
<dc:identifier>10.1007/S10072-022-06226-1</dc:identifier>
<dc:identifier>1590-3478</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Neurological Sciences. 2022, V. 43, n. 10, p. 6079-6085</dc:relation>
<dc:relation>https://doi.org/10.1007/s10072-022-06226-1</dc:relation>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>Application/pdf</dc:format>
<dc:publisher>Springer Nature</dc:publisher>
<europeana:object>https://riubu.ubu.es/bitstream/10259/12173/4/Saiz-ns_2022.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://creativecommons.org/licenses/by/4.0/</europeana:rights>
<europeana:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</europeana:dataProvider>
<europeana:isShownAt>https://hdl.handle.net/10259/12173</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>